This study will examine the efficacy of the medication gemfibrozil in reducing alcohol
consumption in individuals with an alcohol use disorder who are seeking treatment for
alcohol-related problems. Twenty individuals will be randomized to receive four weeks of
either gemfibrozil or placebo and retrospective reports of alcohol use will be collected
throughout the trial. In addition, brain imaging measures will be collected at baseline and
after two weeks of treatment to determine the effects of gemfibrozil on brain functioning.